NYSEAMERICAN:CCEL Cryo-Cell International (CCEL) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free CCEL Stock Alerts $7.75 -0.17 (-2.15%) (As of 12:18 PM ET) Add Compare Share Share Today's Range$7.50▼$7.7650-Day Range$5.03▼$6.1452-Week Range$3.67▼$8.15Volume1,906 shsAverage Volume9,770 shsMarket Capitalization$62.78 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestStock AnalysisChartDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest Get Cryo-Cell International alerts: Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Cryo-Cell International Stock (NYSEAMERICAN:CCEL)Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.Read More CCEL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CCEL Stock News HeadlinesApril 15, 2024 | msn.comCCEL Stock Earnings: Cryo-Cell International Beats EPS, Misses Revenue for Q1 2024April 15, 2024 | businesswire.comCord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial ResultsApril 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 26, 2024 | markets.businessinsider.comCryo-Cell Plans To Explore Strategic Alternatives And Spin-off Of Celle SubsidiaryMarch 23, 2024 | finance.yahoo.comCryo-Cell International, Inc. (CCEL)March 14, 2024 | msn.comUnveiling the Molecular Dance Capturing the Activation of Cell Receptors through Cryo-Electron MicroscopyFebruary 28, 2024 | businesswire.comCryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023February 14, 2024 | wsj.comCryo-Cell International Inc.April 23, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.February 5, 2024 | seekingalpha.comInvitae plunges amid report it may file for bankruptcy within weeks (update)October 14, 2023 | markets.businessinsider.comStrong Performance and Growth Potential Drive Buy Rating for Cryo-Cell International: An Analysis by Allen KleeOctober 12, 2023 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial ResultsAugust 31, 2023 | benzinga.comCryo-electron Microscopy Market worth $2.1 billion by 2028July 19, 2023 | markets.businessinsider.comMaxim Group Keeps Their Buy Rating on Cryo-Cell International (CCEL)July 14, 2023 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial ResultsMay 4, 2023 | marketwatch.comStem Cell Services Market to Receive Overwhelming Hike in Revenues by 2030 With key Players Paragon Bioservices, APEX Biologix, VcanBio, Cryo-cellApril 28, 2023 | marketwatch.comCell Banking Outsourcing Market Research Analysis 2023-2031April 27, 2023 | marketwatch.comGlobal Cord Blood Stem Cells Market by [2023-2029] with Revenue OutsourcingApril 24, 2023 | msn.comLooking Into Cryo-Cell International's Return On Capital EmployedApril 21, 2023 | msn.comCPS Technologies CEO resignsApril 21, 2023 | msn.comCRYO-CELL International GAAP EPS of $0.09 beats by $0.13, revenue of $7.82M beats by $0.41MApril 21, 2023 | finance.yahoo.comCord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial ResultsMarch 30, 2023 | marketwatch.com2023-2029 Cord Stem Cell Banking Market Size and Industrial Analysis with Market Dynamics | Latest Report by Absolute ReportsMarch 22, 2023 | marketwatch.comCell Banking Outsourcing Market Outlook by 2031March 1, 2023 | msn.comCRYO-CELL International GAAP EPS of $0.33 beats by $0.20, revenue of $30.3M beats by $0.46MMarch 1, 2023 | finance.yahoo.comCryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022February 22, 2023 | seekingalpha.comCCEL Cryo-Cell International, Inc.See More Headlines Receive CCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/15/2024Today4/23/2024Fiscal Year End11/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSEAMERICAN:CCEL CUSIPN/A CIK862692 Webwww.cryo-cell.com Phone(813) 749-2100Fax813-855-4745Employees82Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.16) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,520,000.00 Net Margins-31.02% Pretax Margin-43.94% Return on Equity-64.31% Return on Assets5.47% Debt Debt-to-Equity RatioN/A Current Ratio0.49 Quick Ratio0.45 Sales & Book Value Annual Sales$31.34 million Price / Sales2.05 Cash Flow$0.70 per share Price / Cash Flow11.26 Book Value($1.33) per share Price / Book-5.95Miscellaneous Outstanding Shares8,100,000Free Float5,263,000Market Cap$64.15 million OptionableNot Optionable Beta0.45 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. David I. Portnoy (Age 61)Chairman & Co-CEO Comp: $1.45MMr. Mark L. Portnoy (Age 60)Co-CEO & Director Comp: $990kMs. Jill M. Taymans (Age 54)CFO & VP of Finance Comp: $254.77kMr. Oleg Mikulinsky (Age 51)Chief Information Officer Comp: $382.77kDr. Joanne Kurtzberg M.D.Medical Director and Member of Medical & Scientific Advisory BoardKey CompetitorsCurative BiotechnologyOTCMKTS:CUBTKronos BioNASDAQ:KRONTurnstone BiologicsNASDAQ:TSBXMural OncologyNASDAQ:MURAVaxxinityNASDAQ:VAXXView All CompetitorsInstitutional OwnershipMassmutual Trust Co. FSB ADVSold 3,178 shares on 4/9/2024Ownership: 1.339%Rowlandmiller & PARTNERS.ADVBought 14,433 shares on 4/8/2024Ownership: 0.174%View All Institutional Transactions CCEL Stock Analysis - Frequently Asked Questions Are investors shorting Cryo-Cell International? Cryo-Cell International saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 21,900 shares, a decline of 17.4% from the March 15th total of 26,500 shares. Based on an average daily volume of 9,900 shares, the days-to-cover ratio is presently 2.2 days. Approximately 0.5% of the company's shares are sold short. View Cryo-Cell International's Short Interest. How were Cryo-Cell International's earnings last quarter? Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) posted its quarterly earnings results on Monday, April, 15th. The company reported $0.07 earnings per share (EPS) for the quarter. The business earned $7.85 million during the quarter. Cryo-Cell International had a negative trailing twelve-month return on equity of 64.31% and a negative net margin of 31.02%. Who are Cryo-Cell International's major shareholders? Cryo-Cell International's stock is owned by many different retail and institutional investors. Top institutional shareholders include Massmutual Trust Co. FSB ADV (1.34%) and Rowlandmiller & PARTNERS.ADV (0.17%). View institutional ownership trends. How do I buy shares of Cryo-Cell International? Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:CCEL) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryo-Cell International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
